|
RAPP Rapport Therapeutics Inc 2012593 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-56,615,000.00 |
| Balance Sheet |
|
Current Assets
|
$446,856,000.00 |
|
Assets
|
$458,982,000.00 |
|
Current Liabilities
|
$28,424,000.00 |
|
Liabilities
|
$36,056,000.00 |
|
Equity
|
$422,926,000.00 |
|
Shares Out
|
47955079.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-54,516,000.00 |
|
Investing Cash Flow
|
$63,541,000.00 |
| Market Analysis |
Market Cap
|
$2,294,650,530.15 |
|
Price
|
$47.85 |
|
BVPS
|
8.82 |
|
PB
|
5.43 |
|
EPS
|
-1.19 |
|
PS
|
23.29 |
|
FCF
|
$-54,680,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:31 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:21 |
|
| Apr |
May |
Jun |
| 2026-03-10 |
-0.72 |
|
|
2026-05-07 |
-0.42 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.75 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.71 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RAPP documents filed with the SEC.
RAPP Filings
Clear
